Castle Rock Innovations
2
60M
1
0.11
0.50
1
- Areas of investment
Summary
Castle Rock Innovations appeared to be the Corporate Investor, which was created in 2003. The main office of represented Corporate Investor is situated in the Chicago. The fund was located in North America if to be more exact in United States.
The high activity for fund was in 2003. Deals in the range of 50 - 100 millions dollars are the general things for fund. The top amount of exits for fund were in 2006. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Oxford Bioscience Partners, Jafco Life Science, Cogene Ventures. In the next rounds fund is usually obtained by Sofinnova Investments, RCT BioVentures, Novartis Venture Fund.
This organization was formed by Khashayar Sarrafi, Michael Marr.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Medical. Among the most popular portfolio startups of the fund, we may highlight Catalyst Biosciences. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.11
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (2)
- Pharmaceutical (2)
- Medical (2)
- Therapeutics (2)
- Health Care (2) Show 2 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2003
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Catalyst Biosciences | 20 Mar 2003 | Biotechnology, Health Care, Medical Device, Medical, Life Science, Pharmaceutical, Therapeutics | Early Stage Venture | 60M | United States, California, South San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.